- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Influenza Research and Treatment
Volume 2010 (2010), Article ID 976084, 3 pages
Shedding of the Pandemic Swine-Origin Influenza A Virus (H1N1) after Oseltamivir Administration
1Unit of Viral Genome Regulation, Institut Pasteur of Shanghai, The Key Laboratory of Virology and Immunology, Chinese Academy of Sciences, 411 Hefei Road, Shanghai 200025, China
2Emerging Infectious Diseases, Institut Pasteur of Shanghai, The Key Laboratory of Virology and Immunology, Chinese Academy of Sciences, 411 Hefei Road, Shanghai 200025, China
3Institut Pasteur in Cambodia, 5 Monivong Boulevard, P.O. Box 983, Phnom Penh, Cambodia
4Choju Medical Institute, Fukushimura Hospital, 19-4 Azanakayama, Noyori-cho, Toyohashi, Aichi 441-8124, Japan
5Infectious Disease Regulation Project, Tokyo Metropolitan Institute of Medical Sciences, 1-6, Kamikitazawa 2-chome, Setagaya-ku, Tokyo156-8506, Japan
Received 1 October 2010; Revised 5 November 2010; Accepted 15 November 2010
Academic Editor: Daniel Roberto Perez
Copyright © 2010 Leiyun Weng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- WHO, “World now at the start of 2009 influenza pandemic,” http://www.who.int/csr/don/2009_10_02/en/index.html.
- B. Cao, X. W. Li, YU. Mao et al., “Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China,” The New England Journal of Medicine, vol. 361, no. 26, pp. 2507–2517, 2009.
- E. van der Vries, M. Jonges, S. Herfst et al., “Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase,” Journal of Clinical Virology, vol. 47, no. 1, pp. 34–37, 2010.
- R. J. Hall, M. P. Peacey, J. C. Ralston et al., “Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir,” Eurosurveillance, vol. 14, no. 30, p. 19282, 2009.
- E. Hoffmann, J. Stech, Y. Guan, R. G. Webster, and D. R. Perez, “Universal primer set for the full-length amplification of all influenza A viruses,” Archives of Virology, vol. 146, no. 12, pp. 2275–2289, 2001.
- F. G. Hayden, J. J. Treanor, R. S. Fritz et al., “Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment,” Journal of the American Medical Association, vol. 282, no. 13, pp. 1240–1246, 1999.
- S. Leekha, N. L. Zitterkopf, M. J. Espy, T. F. Smith, R. L. Thompson, and P. Sampathkumar, “Duration of influenza A virus shedding in hospitalized patients and implications for infection control,” Infection Control and Hospital Epidemiology, vol. 28, no. 9, pp. 1071–1076, 2007.
- H. Fleury, S. Burrel, C. Balick Weber et al., “Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009,” Eurosurveillance, vol. 14, no. 49, Article ID 19434, 2009.
- L. M. Ling, A. L. Chow, D. C. Lye et al., “Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection,” Clinical Infectious Diseases, vol. 50, no. 7, pp. 963–969, 2010.
- G. Boivin, Z. Coulombe, and C. Wat, “Quantification of the influenza virus load by real-time polymerase chain reaction in nasopharyngeal swabs of patients treated with oseltamivir,” Journal of Infectious Diseases, vol. 188, no. 4, pp. 578–580, 2003.